B

Bioretec Oy
OMXH:BRETEC

Watchlist Manager
Bioretec Oy
OMXH:BRETEC
Watchlist
Price: 1.67 EUR -4.02%
Market Cap: 41.1m EUR

Wall Street
Price Targets

BRETEC Price Targets Summary
Bioretec Oy

Wall Street analysts forecast BRETEC stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for BRETEC is 2.74 EUR with a low forecast of 2.71 EUR and a high forecast of 2.82 EUR.

Lowest
Price Target
2.71 EUR
62% Upside
Average
Price Target
2.74 EUR
64% Upside
Highest
Price Target
2.82 EUR
69% Upside
Bioretec Oy Competitors:
Price Targets
214150
Classys Inc
26% Upside
EUZ
Eckert & Ziegler Strahlen und Medizintechnik AG
4% Upside
301367
BMC Medical Co Ltd
14% Upside
GEHC
GE Healthcare Technologies Inc
24% Upside
228850
Rayence Co Ltd
20% Upside
7779
Cyberdyne Inc
67% Upside
MASI
Masimo Corp
13% Upside
ALCAR
Carmat SA
345% Upside

Revenue
Forecast

Revenue Estimate
Bioretec Oy

For the last 5 years the compound annual growth rate for Bioretec Oy's revenue is 21%. The projected CAGR for the next 3 years is 82%.

21%
Past Growth
82%
Estimated Growth
Estimates Accuracy
-3%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Bioretec Oy

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-1%
Average Miss

Net Income
Forecast

Net Income Estimate
Bioretec Oy

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-24%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is BRETEC's stock price target?
Price Target
2.74 EUR

According to Wall Street analysts, the average 1-year price target for BRETEC is 2.74 EUR with a low forecast of 2.71 EUR and a high forecast of 2.82 EUR.

What is Bioretec Oy's Revenue forecast?
Projected CAGR
82%

For the last 5 years the compound annual growth rate for Bioretec Oy's revenue is 21%. The projected CAGR for the next 3 years is 82%.

Back to Top